Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders : KALIGO+

Launched by FONDATION ILDYS · Feb 27, 2025

Keywords

ClinConnect Summary

The KALIGO+ trial is studying a new approach to help children aged 6 to 11 who have difficulties learning how to write. Writing is an important skill for success in school and everyday life, but many children struggle with it. This study will test a special tool called the Kaligo+ solution, which uses technology like tablets to make learning to write more engaging and effective. Researchers want to see if this method can help improve the handwriting skills of children who face significant challenges in writing.

To participate in this study, children need to be between 6 and 11 years old and have some difficulties with writing. They can be receiving other help for their writing issues or not. However, children with severe intellectual disabilities or those who cannot use the tablet or virtual reality will not be included. Participants will use the Kaligo+ solution and their writing progress will be closely monitored. This trial aims to show how this innovative tool can make a difference for children who struggle with writing.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children with writing difficulties (who may or may not be receiving care in this area)
• • Age: 6 - 11 years
• • Score \> 1 standard deviation on the BHK deterioration score
• Exclusion Criteria:
• • Contraindication to the use of the tablet or virtual reality
• • Moderate, severe or profound intellectual disability (Total Intelligence Quotient below 55 on an intellectual efficiency scale such as WISC-V or K-ABC-II).